image
RedHill Biopharma Ltd. RDHL
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - IL
Watchlist
$ 7.29
6.11 %
$ 9.29 M
Market Cap
-0.02
P/E
BALANCE SHEET
23 M ASSETS
-85.49%
Growth Rates
1Year -85.49%
3Years -49.62%
5Years -18.06%
7Years -15.38%
10Years 4.86%
21 M LIABILITIES
-89.88%
Growth Rates
1Year -89.88%
3Years -49.86%
5Years 13.32%
7Years 8.95%
10Years 24.13%
2.07 M EQUITY
104.27%
Growth Rates
1Year 104.27%
3Years -46.96%
5Years -47.36%
7Years -38.57%
10Years -16.07%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition RedHill Biopharma Ltd.
image
Current Assets 16.1 M
Cash & Short-Term Investments 6.36 M
Receivables 3.29 M
Other Current Assets 6.5 M
Non-Current Assets 6.91 M
Long-Term Investments 147 K
PP&E 1.18 M
Other Non-Current Assets 5.58 M
Current Liabilities 19.2 M
Accounts Payable 3.28 M
Short-Term Debt 718 K
Other Current Liabilities 15.2 M
Non-Current Liabilities 1.74 M
Long-Term Debt 455 K
Other Non-Current Liabilities 1.28 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 5.6 20.0 29.5 29.3 29.0 29.0 16.5 53.8 21.5 5.9 11.9 16.8 14.1
Short Term Investments 0.8 15 K 8.5 0.5 18.8 24.2 29.8 12.4 36.6 17.1 0.3 1.6 4.6
Receivables 3.3 37.9 32.5 29.3 1.6 1.4 2.3 0.5 0.2 1.1 0 84 K 19 K
Inventory 4.4 11.0 14.8 6.5 1.9 0.8 0.7 1.1 (34.5) (15.0) (0.4) (1.0) (1.5)
Other Current Assets 2.1 17.0 3.8 4.9 1.8 1.4 2.6 1.2 2.2 2.0 61 K 0.1 70 K
Total Current Assets 16.1 85.9 89.2 70.5 53.2 56.8 51.7 67.8 60.5 26.0 12.6 18.6 18.7
PP&E 1.2 7.2 4.2 5.7 3.8 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1
Intangible Assets 5.6 65.6 71.6 87.9 16.9 5.3 5.3 6.1 6.1 2.6 1.6 1.3 1.2
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0.1 0.2 16.2 16.2 0.2 0.1 0.2 0.1 0.1 76 K 81 K 0 0
Other Long Term Assets 41 0.1 16.2 16.2 (20.7) (5.6) 0.2 0.1 0.1 76 K 81 K 75 K 73 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 23.0 158.9 181.2 180.2 74.1 62.4 57.3 74.2 66.8 28.9 14.3 20.1 20.2
LIABILITIES
Accounts Payable 3.3 4.2 11.7 11.6 4.2 3.3 4.8 60 K 0.1 66 K 0.9 0.3 0.3
Short Term Debt 0.7 116.2 1.6 1.7 0.8 0 0 0 0 0 0 0 0
Other Current Liabilities 15.2 77.0 68.2 60.0 5.6 7.1 7.0 5.3 5.4 1.7 1.5 0.8 0.2
Total Current Liabilities 19.2 197.5 81.5 73.2 10.6 10.4 11.8 5.4 5.5 1.7 2.4 1.1 0.5
Long Term Debt 0.5 6.4 86.2 85.2 3.0 0 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 1.3 3.4 4.6 7.9 0.5 0.8 0.4 6.2 1.2 2.1 0 0 0.9
Total Liabilities 21.0 207.3 172.3 166.4 14.1 11.2 12.3 11.5 6.8 3.8 2.4 1.1 1.4
EQUITY
Common Stock 21.4 2.8 1.5 1.1 1.0 0.8 0.6 0.4 0.3 0.2 0.2 0.1 0.1
Retained Earnings (407.7) (433.9) (367.9) (280.3) (208.4) (169.1) (132.9) (89.6) (61.9) (42.2) (33.3) (23.9) (15.2)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 (0.3) (0.3) (0.2) (0.1) 90 K 63 K 39 K 15 K
Total Equity 2.1 (48.4) 8.9 13.9 60.0 51.2 45.1 62.7 60.1 25.0 11.9 19.0 18.8
Total Liabilities and Equity 23.0 158.9 181.2 180.2 74.1 62.4 57.3 74.2 66.8 28.9 14.3 20.1 20.2
SHARES OUTSTANDING
Common Shares Outstanding 6.5 1.5 1.2 0.9 0.7 0.6 0.4 0.3 0.3 0.2 0.2 0.1 0.1 0.1